Inside world’s biggest cruise ship worth… THE world's biggest cruise ship is preparing to set sail, as it was seen testing the waters ahead of its 2024…
New York office market bolstered by sale valuing… Receive free Commercial property updatesWe’ll send you a myFT Daily Digest email rounding up the latest Commercial!-->!-->…
UK cell therapy start-up agrees AstraZeneca… One of the most promising UK biotech start-ups, Quell Therapeutics, has signed a research collaboration and…
Embracer shares plunge as $2bn deal falls… Shares in Swedish gaming group Embracer plunged nearly 40 per cent on Wednesday after the group slashed its…
Pakistan, Saudi expected to sign deal for USD… Islamabad: Cash-starved Pakistan is likely to ink a deal for additional deposits of USD 2 billion from Saudi…
GSK bets on cough drug with $2bn deal for… GSK has agreed to buy Canadian biotech Bellus Health in a $2bn deal, its largest acquisition since the UK…
Dire $2bn warning on Aussie Olympics The man leading planning for the 2032 Brisbane Olympic Games has warned Australia risks failure without urgent…
Man Utd takeover LIVE – £2bn promise made… Luke Shaw admits that confidence is flowing through the Manchester United dressing room ahead of Sunday's Carabao…
Aesop reported target in $2bn bidding war… Aesop, an Australian luxury cosmetics, shampoo and bodycare brand, is said to be at the centre of a $2bn (£1.6bn)…